Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1839]

Ten years of hormone therapy reduces breast cancer recurrence without...

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada

Ten years of hormone therapy reduces breast cancer recurrence without compromising quality of life ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )

Patient engagement in The Metastatic Breast Cancer Project

Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA

Patient engagement in The Metastatic Breast Cancer Project ( Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA )

Liquid biopsy may help guide treatment decisions for advanced solid tumours

Prof Philip Mack - University of California Davis, Davis, USA

Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )

Innovative direct-to-patient outreach may accelerate breast cancer research

Dr Nikhil Wagle - Dana Farber Cancer Institute, Boston, USA

Innovative direct-to-patient outreach may accelerate breast cancer research ( Dr Nikhil Wagle - Dana Farber Cancer Institute, Boston, USA )

Liquid biopsy may help guide treatment decisions for advanced solid tumours

Prof Philip Mack - University of California Davis, Davis, USA

Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )

First outcome results from MINDACT breast cancer clinical trial

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium

First outcome results from MINDACT breast cancer clinical trial ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

Genetics may influence risk for breast cancer after chest radiotherapy to treat...

Dr Lindsay Morton - National Cancer Institute, Bethesda, USA

Genetics may influence risk for breast cancer after chest radiotherapy to treat childhood cancer ( Dr Lindsay Morton - National Cancer Institute, Bethesda, USA )

A presurgery combination therapy may improve outcomes for women with Her2...

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania...

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )

Direct activation of STING in the tumour microenvironment leads to potent and...

Dr Thomas Dubensky - Aduro Biotech, Berkley, USA

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )

Successes and challenges in designing combination immunotherapy clinical trials...

Prof Leisha Emmens - Johns Hopkins Kimmel Cancer, Baltimore, USA

Successes and challenges in designing combination immunotherapy clinical trials for breast cancer ( Prof Leisha Emmens - Johns Hopkins Kimmel Cancer, Baltimore, USA )

Understanding personalised medicine - the e-learning course

Prof Gordon McVie

Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )

Breast cancer risk prediction models improved by adding multiple biological...

Dr Xuehong Zhang - Dana-Farber Cancer Institute, Boston, USA

Breast cancer risk prediction models improved by adding multiple biological markers of risk ( Dr Xuehong Zhang - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer